<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="26537">Retinoids</z:chebi> such as <z:hpo ids='HP_0000001'>all</z:hpo> trans-<z:chebi fb="2" ids="26536">retinoic acid</z:chebi> (ATRA) have been used as chemopreventive agents for a number of <z:e sem="disease" ids="C0032927" disease_type="Neoplastic Process" abbrv="">premalignant conditions</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>To explore a potential role for <z:chebi fb="0" ids="26537">retinoids</z:chebi> as chemopreventive agents for <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, we studied ATRA's effects on <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in a nonneoplastic, telomerase-immortalized, metaplastic Barrett's cell line </plain></SENT>
<SENT sid="2" pm="."><plain>We treated the Barrett's cells with ATRA in the presence and absence of inhibitors to p53 (pSRZ-siRNA-p53), p38 (SB-203580 and p38 siRNA), and the caspase cascade (z-Val-Ala-Asp-fluoromethyl <z:chebi fb="3" ids="17087">ketone</z:chebi>) </plain></SENT>
<SENT sid="3" pm="."><plain>We determined the effects of ATRA and the various inhibitors on <z:mpath ids='MPATH_3'>apoptosis</z:mpath> using cell <z:mp ids='MP_0000002'>morphology</z:mp>, terminal deoxynucleotidyltransferase-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi> nick-end labeling staining, cleaved caspase-3 immunofluorescence, and Annexin V staining </plain></SENT>
<SENT sid="4" pm="."><plain>We also determined how ATRA in the presence and absence of the inhibitors affected <z:mpath ids='MPATH_3'>apoptosis</z:mpath> following low-dose UV-B irradiation </plain></SENT>
<SENT sid="5" pm="."><plain>ATRA induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and increased the expression of p53 protein in a dose-dependent fashion </plain></SENT>
<SENT sid="6" pm="."><plain>The apoptotic effect of ATRA was abolished by treatment with inhibitors of both p38 and caspase, but not by p53 interfering <z:chebi fb="40" ids="33697">RNA</z:chebi> (RNAi) </plain></SENT>
<SENT sid="7" pm="."><plain>Inhibition of p38 also prevented expression of cleaved caspase-3, suggesting that ATRA activates p38 upstream of the caspase cascade </plain></SENT>
<SENT sid="8" pm="."><plain>We found that ATRA sensitized immortalized Barrett's cells to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induced by low-dose UV-B irradiation via a similar mechanism </plain></SENT>
<SENT sid="9" pm="."><plain>ATRA induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in Barrett's epithelial cells and sensitizes them to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induced by UV-B irradiation via activation of p38 and the caspase cascade, but not through p53 </plain></SENT>
<SENT sid="10" pm="."><plain>This study elucidates molecular pathways whereby <z:chebi fb="0" ids="26537">retinoid</z:chebi> treatment might prevent <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> in Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> and suggests a potential role for the use of safer <z:chebi fb="0" ids="26537">retinoids</z:chebi> for chemoprevention in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
</text></document>